These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 7524760

  • 1. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F, Stroncek D, Verfaillie CM.
    Blood; 1996 Sep 15; 88(6):2033-42. PubMed ID: 8822922
    [Abstract] [Full Text] [Related]

  • 3. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
    Möhle R, Haas R, Hunstein W.
    J Hematother; 1993 Sep 15; 2(4):483-9. PubMed ID: 7522108
    [Abstract] [Full Text] [Related]

  • 4. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
    Tjønnfjord GE, Steen R, Evensen SA, Thorsby E, Egeland T.
    Blood; 1994 Oct 15; 84(8):2795-801. PubMed ID: 7522643
    [Abstract] [Full Text] [Related]

  • 5. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
    Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM.
    Blood; 1997 Jun 01; 89(11):3991-7. PubMed ID: 9166837
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE, Kirby MR, Metzger ME, Agricola BA, Sellers SE, Cullis HM.
    Blood; 1996 Feb 15; 87(4):1644-53. PubMed ID: 8608259
    [Abstract] [Full Text] [Related]

  • 7. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
    Haas R, Möhle R, Pförsich M, Fruehauf S, Witt B, Goldschmidt H, Hunstein W.
    Blood; 1995 Apr 01; 85(7):1936-43. PubMed ID: 7535595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration.
    Steen R, Tjønnfjord GE, Gunnes Grøseth LA, Heldal D, Egeland T.
    J Hematother; 1997 Dec 01; 6(6):563-73. PubMed ID: 9483191
    [Abstract] [Full Text] [Related]

  • 10. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR.
    Blood; 1991 Mar 15; 77(6):1218-27. PubMed ID: 1705833
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R, Tjønnfjord GE, Egeland T.
    J Hematother; 1994 Mar 15; 3(4):253-62. PubMed ID: 7537606
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T, Muroi K, Tomizuka H, Amemiya Y, Miura Y.
    Stem Cells; 1995 May 15; 13(3):273-80. PubMed ID: 7542113
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 15; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO, Humeau L, Paek B, Ohkubo T, Lanier LL, Albanese CT, Bárcena A.
    Exp Hematol; 2000 Aug 15; 28(8):961-73. PubMed ID: 10989197
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK.
    Exp Hematol; 1994 Feb 15; 22(2):157-65. PubMed ID: 7507857
    [Abstract] [Full Text] [Related]

  • 20. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
    Fruehauf S, Haas R, Conradt C, Murea S, Witt B, Möhle R, Hunstein W.
    Blood; 1995 May 01; 85(9):2619-26. PubMed ID: 7537123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.